New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 11, 2014
10:35 EDTCYTR, HZNP, NBR, IPG, SNV, NIHigh option volume stocks: HZNP NI IPG CYTR SNV NBR
News For HZNP;NI;IPG;CYTR;SNV;NBR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 21, 2015
10:14 EDTCYTRHigh option volume stocks:
Subscribe for More Information
09:21 EDTCYTROn The Fly: Pre-market Movers
Subscribe for More Information
08:47 EDTCYTRCytRx 9.1M share Spot Secondary priced at $2.75
Subscribe for More Information
07:02 EDTHZNPHorizon Pharma increases offer for Depomed to $33.00 per share
Horizon Pharma (HZNP) announced that it has increased the value of its all-stock acquisition proposal to $33.00 per share from $29.25 per share, contingent on Depomed entering into good faith discussions regarding a transaction. The increased offer represents a 60% premium to the closing price of Depomed on July 6, the day prior to when Horizon's initial proposal was made public.
07:01 EDTHZNPHorizon Pharma increases offer for Depomed to $33.00 per share
06:34 EDTSNVSynovus reports Q2 EPS 40c, consensus 39c
Subscribe for More Information
July 20, 2015
19:02 EDTCYTROn The Fly: After Hours Movers
Subscribe for More Information
16:02 EDTCYTRCytRx files to sell common stock, no amount given
Jefferies LLC is the sole book-running manager for the offering.
15:01 EDTSNVNotable companies reporting before tomorrow's open
Subscribe for More Information
10:33 EDTHZNPDepomed suitor Horizon Pharma advances after raising outlook
Subscribe for More Information
09:50 EDTHZNPHorizon Pharma CEO says 'here to stick it out' regarding Depomed deal
Subscribe for More Information
09:50 EDTHZNPHorizon Pharma CEO says Depomed proposal 'shareholder friendly'
Subscribe for More Information
09:22 EDTHZNPOn The Fly: Pre-market Movers
Subscribe for More Information
07:16 EDTHZNPHorizon Pharma up 5.2% after reporting preliminary Q2 revenue, raises FY15 view
Subscribe for More Information
07:05 EDTHZNPHorizon Pharma raises FY15 revenue guidance to $660M-$680M from $590M-$610M
Consensus $611.6M. Raises FY15 adjusted EBITDA guidance to $265M-$280M from $235M-$250M.
07:04 EDTHZNPHorizon Pharma sees Q2 revenue $170M-$172M, consensus $138.26M
July 17, 2015
16:55 EDTNBRC&J Energy announces filing of shelf registration statements
Subscribe for More Information
July 16, 2015
10:04 EDTHZNPHigh option volume stocks
High option volume stocks: TWX PMCS SHW ASML GRMN GSAT ROVI ALLY LC HZNP
10:00 EDTNBROn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:40 EDTNBRNabors Industries initiated with a Neutral at Citi
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use